Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Read More 3 minute read Pharma Industry News Recce Pharmaceuticals secures phase II trial safety approval for breakthrough R327G treatment Recce Pharmaceuticals Limited recently announced significant progress in its phase II clinical trial for RECCE 327 Topical Gel… byPallavi MadhirajuOctober 28, 2024